Breaking News Instant updates and real-time market news.

WWE

WWE

$37.03

-0.49 (-1.31%)

16:49
04/09/18
04/09
16:49
04/09/18
16:49

WWE closes well off lows after releasing WrestleMania viewer data

Shares of World Wrestling Entertainment (WWE), the media company behind the production and distribution of wrestling content through various channels, including its WWE Network, television rights agreements, pay-per-view event programming, and live events, spiked higher in late afternoon trading following a press release from the company that showed a 9% increase in WrestleMania viewers on Sunday night. WRESTLEMANIA: WWE announced that its digital streaming service, WWE Network, reached a record 2.12M total subscribers following Sunday night's WrestleMania. This is a 9% increase from April 3, 2017, the day after WrestleMania last year. "We expect to deliver record subscriber levels, revenue and adjusted OIBDA in 2018," said WWE co-president George Barrios. "WWE Network's continued growth along with our massive reach across traditional television as well as digital and social platforms, reaffirms the effectiveness of our global, multi-platform content strategy." GUIDANCE: In addition to the WrestleMania data, the WWE release featured raised guidance both for Q1 and FY18. The WWE now sees Q1 adjusted OIBDA -- or Operating Income Before Depreciation and Amortization -- of at least $30M, exceeding its previous guidance of $23M-$27M. For FY18, the WWE sees adjusted OIBDA of at least $145M, exceeding its previous guidance of at least $140M. That number, if reached, would be an all-time record. PRICE ACTION: While shares of WWE still closed down 1.3% in Monday's session, closing at $37.03, they spiked higher following the company's late day release, and finished the day well off their intraday low of $36.28.

  • 09

    Apr

  • 19

    Apr

WWE WWE
$37.03

-0.49 (-1.31%)

03/07/18
NEED
03/07/18
NO CHANGE
Target $45
NEED
Buy
WWE price target raised to $45 from $38 at Needham
Needham analyst Laura Martin raised her price target on WWE to $45 and kept her Buy rating, citing several near-term and longer term positive catalysts. In the short run, Martin points to favorable TV license fee renewals in the U.S., U.K., and India markets along with the OTT subscription seen in U.S. and overseas. Over the long term, the analyst notes the company's potential to increase the total addressable market with more "women and globally relevant wrestlers" becoming central in WWE's events. Martin adds that the longer term positives include slowing costs and rising international revenue streams.
02/12/18
KEYB
02/12/18
UPGRADE
Target $43
KEYB
Overweight
WWE upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Evan Wingren upgraded WWE to Overweight with a $43 price target. The analyst expects operating leverage expansion from the company's TV renewal cycle and increasing digital content opportunities. He sees further upside in the shares despite the recent rally.
02/11/18
KEYB
02/11/18
UPGRADE
KEYB
Overweight
WWE upgraded to Overweight from Sector Weight at KeyBanc
01/30/18
01/30/18
UPGRADE
Target $40

Overweight
WWE upgraded on rights renewals, strategic potential at Morgan Stanley
As previously reported, Morgan Stanley analyst Benjamin Swinburne upgraded WWE to Overweight from Equal Weight, arguing that the race for sports rights and exclusive content should accelerate the company's revenue growth over the next 2-3 years. Meanwhile, over the same time frame WWE's cost base should continue to grow at a controlled pace, estimates Swinburne. He also believes WWE is a potentially interesting strategic asset in the rapidly consolidating world of media, he added. Swinburne raised his price target to $40 from $23 on WWE shares.

TODAY'S FREE FLY STORIES

SQ

Square

$63.00

-7.545 (-10.70%)

06:43
11/20/18
11/20
06:43
11/20/18
06:43
Recommendations
Square analyst commentary  »

Square price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 12

    Dec

  • 18

    Dec

CBM

Cambrex

$47.67

0.41 (0.87%)

06:42
11/20/18
11/20
06:42
11/20/18
06:42
Hot Stocks
Cambrex to acquire Avista Pharma Solutions for approximately $252M »

Cambrex announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QLYS

Qualys

$69.24

-5.355 (-7.18%)

06:41
11/20/18
11/20
06:41
11/20/18
06:41
Upgrade
Qualys rating change  »

Qualys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Jan

JD

JD.com

$21.09

-1.95 (-8.46%)

06:38
11/20/18
11/20
06:38
11/20/18
06:38
Downgrade
JD.com rating change  »

JD.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$21.09

-1.95 (-8.46%)

06:35
11/20/18
11/20
06:35
11/20/18
06:35
Periodicals
JD.com CEO says focus will be on strategy, new businesses, Yicai reports »

JD.com founder and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRL

Hormel Foods

$45.36

-0.535 (-1.17%)

06:35
11/20/18
11/20
06:35
11/20/18
06:35
Earnings
Breaking Earnings news story on Hormel Foods »

Hormel Foods sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TGT

Target

$77.13

-1.9 (-2.40%)

06:34
11/20/18
11/20
06:34
11/20/18
06:34
Earnings
Breaking Earnings news story on Target »

Target sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

TGT

Target

$77.13

-1.9 (-2.40%)

06:34
11/20/18
11/20
06:34
11/20/18
06:34
Hot Stocks
Breaking Hot Stocks news story on Target »

Target sees Q4 SSS up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

MMS

Maximus

$63.91

-2.05 (-3.11%)

06:33
11/20/18
11/20
06:33
11/20/18
06:33
Earnings
Maximus sees FY19 revenue $2.95B-$3.0B, consensus $2.53B »

Sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TGT

Target

$77.13

-1.9 (-2.40%)

06:33
11/20/18
11/20
06:33
11/20/18
06:33
Earnings
Target reports Q3 adj. EPS $1.09, consensus $1.12 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

HRL

Hormel Foods

$45.36

-0.535 (-1.17%)

06:32
11/20/18
11/20
06:32
11/20/18
06:32
Earnings
Hormel Foods reports Q4 adj. EPS 51c, consensus 49c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MMS

Maximus

$63.91

-2.05 (-3.11%)

06:31
11/20/18
11/20
06:31
11/20/18
06:31
Earnings
Maximus reports Q4 revenue $558.4M, consensus $587.58M »

Reports Q4 EPS 71c vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HSDT

Helius Medical

$8.02

-0.08 (-0.99%)

06:31
11/20/18
11/20
06:31
11/20/18
06:31
Upgrade
Helius Medical rating change  »

Helius Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWD

Woodward

$79.45

-2.46 (-3.00%)

06:30
11/20/18
11/20
06:30
11/20/18
06:30
Upgrade
Woodward rating change  »

Woodward upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

QEP

QEP Resources

06:27
11/20/18
11/20
06:27
11/20/18
06:27
Upgrade
QEP Resources rating change  »

QEP Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$45.12

-1.48 (-3.18%)

06:27
11/20/18
11/20
06:27
11/20/18
06:27
Downgrade
Western Digital rating change  »

Western Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EQIX

Equinix

, KNX

Knight-Swift

$32.23

0.51 (1.61%)

06:26
11/20/18
11/20
06:26
11/20/18
06:26
Recommendations
Equinix, Knight-Swift analyst commentary  »

Equinix, Knight-Swift…

EQIX

Equinix

KNX

Knight-Swift

$32.23

0.51 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 10

    Dec

DHI

D.R. Horton

$34.98

0.19 (0.55%)

, KSU

Kansas City Southern

$98.99

-1.795 (-1.78%)

06:26
11/20/18
11/20
06:26
11/20/18
06:26
Recommendations
D.R. Horton, Kansas City Southern analyst commentary  »

D.R. Horton, Kansas City…

DHI

D.R. Horton

$34.98

0.19 (0.55%)

KSU

Kansas City Southern

$98.99

-1.795 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 05

    Dec

SWKS

Skyworks

06:25
11/20/18
11/20
06:25
11/20/18
06:25
Downgrade
Skyworks rating change  »

Skyworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$35.26

-1.15 (-3.16%)

06:25
11/20/18
11/20
06:25
11/20/18
06:25
Downgrade
Teradyne rating change  »

Teradyne downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$21.08

-0.75 (-3.44%)

, ACHC

Acadia

$32.05

-0.51 (-1.57%)

06:23
11/20/18
11/20
06:23
11/20/18
06:23
Periodicals
KKR still in talks to buy Acadia Healthcare, NY Post reports »

KKR (KKR) is still deep…

KKR

KKR

$21.08

-0.75 (-3.44%)

ACHC

Acadia

$32.05

-0.51 (-1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$78.54

-0.79 (-1.00%)

, AET

Aetna

$207.68

-1.49 (-0.71%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Hot Stocks
CVS Health, Aetna deal expected to close after Thanksgiving holiday »

In connection with the…

CVS

CVS Health

$78.54

-0.79 (-1.00%)

AET

Aetna

$207.68

-1.49 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$32.46

-1.22 (-3.62%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Downgrade
Ciena rating change  »

Ciena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Helius Medical rating change  »

Helius Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QLYS

Qualys

$69.24

-5.355 (-7.18%)

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Qualys rating change  »

Qualys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.